Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-17 4:32 pm Sale | 2021-05-17 | 13G | Lyra Therapeutics, Inc. LYRA | RA Capital Management, L.P. | 0 0.000% | -16,317![]() (Position Closed) | Filing History |
| 2021-05-06 4:33 pm Purchase | 2021-05-04 | 13D | Werewolf Therapeutics, Inc. HOWL | RA Capital Management, L.P. | 3,968,583 14.400% | 3,968,583![]() (New Position) | Filing History |
| 2021-05-05 4:39 pm Purchase | 2021-04-27 | 13G | Seres Therapeutics, Inc. MCRB | RA Capital Management, L.P. | 235,110 5.100% | 235,110![]() (New Position) | Filing History |
| 2021-04-16 4:34 pm Purchase | 2021-04-06 | 13D | Achilles Therapeutics plc ACHL | RA Capital Management, L.P. | 5,014,687 12.340% | 5,014,687![]() (New Position) | Filing History |
| 2021-04-07 4:32 pm Unchanged | 2020-04-01 | 13G | Defiance Trillion Dollar Club Index ETF TRIL | RA Capital Management, L.P. | 5,290,481 5.100% | 0 (Unchanged) | Filing History |
| 2021-04-07 4:31 pm Unchanged | 2021-04-01 | 13G | Atea Pharmaceuticals, Inc. AVIR | RA Capital Management, L.P. | 5,368,451 6.500% | 0 (Unchanged) | Filing History |
| 2021-04-07 4:30 pm Purchase | 2021-04-01 | 13G | Bolt Biotherapeutics, Inc. BOLT | RA Capital Management, L.P. | 118,916 6.500% | 118,916![]() (New Position) | Filing History |
| 2021-03-30 4:43 pm Purchase | 2021-03-24 | 13G | Vaxcyte, Inc. PCVX | RA Capital Management, L.P. | 3,865,808 7.530% | 155,109![]() (+4.18%) | Filing History |
| 2021-03-29 4:30 pm Purchase | 2021-03-19 | 13D | Connect Biopharma Holdings Limited CNTB | RA Capital Management, L.P. | 6,640,417 11.500% | 6,640,417![]() (New Position) | Filing History |
| 2021-03-24 4:30 pm Purchase | 2021-03-18 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | RA Capital Management, L.P. | 2,850,000 6.000% | 2,850,000![]() (New Position) | Filing History |
| 2021-03-23 4:32 pm Purchase | 2009-02-28 | 13D | Solid Biosciences Inc. SLDB | RA Capital Management, L.P. | 824,525 11.600% | 159,420![]() (+23.97%) | Filing History |
| 2021-03-15 4:38 pm Purchase | 2021-03-10 | 13G | Viridian Therapeutics, Inc. VRDN | RA Capital Management, L.P. | 388,385 6.300% | 388,385![]() (New Position) | Filing History |
| 2021-03-09 4:30 pm Purchase | 2021-03-02 | 13G | ARYA Sciences Acquisition Corp IV ARYD | RA Capital Management, L.P. | 1,000,000 6.700% | 1,000,000![]() (New Position) | Filing History |
| 2021-03-02 4:32 pm Purchase | 2009-02-28 | 13D | Satsuma Pharmaceuticals, Inc. STSA | RA Capital Management, L.P. | 5,914,252 18.800% | 1,232,394![]() (+26.32%) | Filing History |
| 2021-02-19 4:30 pm Purchase | 2021-02-09 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 556,049 30.000% | 556,049![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RA Capital Management, L.P. | 0 0.000% | -761,666![]() (Position Closed) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Orchard Therapeutics plc ORTX | RA Capital Management, L.P. | 1,231,521 12.600% | 195,056![]() (+18.82%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Novavax, Inc. NVAX | RA Capital Management, L.P. | 3,788,564 6.000% | 3,788,564![]() (New Position) | Filing History |
| 2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL | RA Capital Management, L.P. | 0 0.000% | -3,363,605![]() (Position Closed) | Filing History |
| 2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | RA Capital Management, L.P. | 4,179,067 9.500% | -1,243,245![]() (-22.93%) | Filing History |

